Ascension expands with $21m series D:
This article was originally published in Clinica
Ascension Orthopedics is to grow its product offerings and expand its sales network with the $21m raised in a series D financing. The investment round was led by Frazier Healthcare Ventures. Austin, Texas-based Ascension, which specialises in orthopaedic implants for the upper and lower extremities, also announced the appointment of Andrew Miclot as CEO. With over 25 years' experience in the orthopaedics industry, Mr Miclot has held senior management roles at Orthofix, Zimmer, DePuy and Symmetry Medical.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.